SBIR/STTR Research Award

Novel mass spectrometry methods for profiling modified RNA nucleotides in the nervous system

Award identifier e54aa85e5c3f2d1176c84043429e6d96373cb7b2a0288cec849705dd2e91359dAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$177,206

Program and phase

STTR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Ribonova Inc.
Proposal award date
2015-02-01
Contract end date
2016-01-31
UEI
L9NJDJ177B39
Solicitation number
DA15-002
Topic code
NIDA

Research abstract

DESCRIPTION provided by applicant Pseudouridine is the most abundant post transcriptionally modified nucleoside found in ribonucleic acid RNA Pseudouridine is an enzymatically generated isomer of the canonical base uridine with additional hydrogen bonding capabilities and appears to lead to local structural and biochemical effects within RNAs Pseudouridine has been detected in several types of RNA including ribosomal RNA rRNA transfer RNA tRNA small nuclear RNA snRNA and may be present in messenger RNA mRNA The prevalence of pseudouridine appears to track its biological importance It has been implicated in a wide variety of cellular processes including gene expression gene regulation and steroid receptor signaling through pseudouridylation of the steroid receptor RNA activator SRA The role of pseudouridine in gene expression is mediated through the stabilization of codon anticodon interactions within the ribosome read through of stop codons through unusual base pairing attenuation of gene expression stress induced alternative splicing rRNA stability and ribosome assembly Recent results demonstrate that pseudouridine in mRNA can be translated by the ribosome The current interest in determining the medical significance of post transcriptionally modified nucleosides in RNA requires a new method that is capable of rapidly and conveniently identifying pseudouridine quantifying this modified nucleoside and determining its location within large RNA molecules This proposal seeks to conduct the necessary proof of concept experiments to develop a mass spectrometry MS based selected reaction monitoring SRM assay for pseudouridine that can be used to detect and localize this modified nucleoside within mammalian RNAs including RNAs from cells in the nervous system The proposed research plan addresses two aims Definition of technical specifications for the SRM assay including limits of detection and quantification dynamic range complexity of RNA sample and accuracy of pseudouridine detection quantification and sequence placement and Demonstration of the utility of this assay for monitoring this critical modified nucleoside in human RNAs obtained from cell lines and tissue samples The research will also define the appropriate sample preparation steps required for turn key analysis of RNA by the MS based SRM assay Success in this project will support the development of a reagent kit for use by the scientific community to investigate the clinical significance of this most prevalent RNA modification The project will also examine the applicability of this assay to biopsy materials which could enable its use for research into a wide range of disorders of the nervous system PUBLIC HEALTH RELEVANCE Pseudouridine is the most abundant post transcriptionally modified nucleoside found in ribonucleic acids This project will conduct the necessary proof of concept experiments to develop a mass spectrometry based assay for pseudouridine that can be used to detect quantify and locate this modified nucleoside in RNAs from a variety of mammalian cells Success in this project will enable the development of a reagent kit for use by the medical research community to investigate the clinical significance of this prevalent RNA modification in a wide range of disorders of the nervous system

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

4 SBIR/STTR records share this UEI (2015–2018). Reported award amounts total $2,572,865. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.